ViewRay has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an updated version of its MRIdian MRI-guided radiation therapy system.
The new features of MRIdian A3i include new MRI sequences, on-table autocontouring tools, automated workflow, multiplanar tissue tracking, and automated beam gating.
Currently, 46 MRIdian systems are installed around the globe, according to ViewRay.
